GlassScriptPhysician profile
Matthew Michael Fourman
NPI 1881868347
$491,924.08
in general payments reported to CMS, 2019-2025
19 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133K · 2020: $101K · 2021: $104K · 2022: $59K · 2023: $50K · 2024: $24K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $81K · Travel and Lodging: $6,532 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Food and Beverage: $1,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $81,271.80 |
| Travel and Lodging | $6,532.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Food and Beverage | $1,924.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $489,980.93 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Boston Scientific Corporation | $944.66 | 2025 | Orise |
| Medtronic USA, INC. | $542.15 | 2019 | |
| Conmed Corporation | $99.19 | 2019-2023 | Conmed Specimen Retrieval, Airseal |
| Baxter Healthcare | $83.03 | 2023 | Tisseel |
| Kerecis Limited | $35.73 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hologic Sales and Service, LLC | $24.14 | 2025 | Coolseal Generator |
| Avanos Medical | $23.29 | 2021 | |
| Shield Therapeutics INC | $21.85 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.69 | 2022 | |
| Tela Bio, INC. | $21.31 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Novo Nordisk INC | $18.90 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $18.09 | 2025 | Imcivree |
| Solventum Corporation | $16.64 | 2025 | Activ.A.C. |
| Lilly USA, LLC | $16.01 | 2025 | Zepbound, Mounjaro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $15.53 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.10 | 2023 | Exparel |
| Medtronic, INC. | $13.72 | 2023 | Swiftset |
| Acacia Pharma INC | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Fourman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.